Filter results
You can narrow down the results using the filters
Audience
Publication type
Topics
Our work
Diseases
      9728 results
    
    - 
  
    
Practice Incentives Program – Quality improvement measuresThis document explains quality improvement measures for general practice under the Practice Incentives Program (PIP) Quality Improvement (QI) Incentive.
- 
  
    
Practice Incentives Program Quality Improvement Incentive – Frequently asked questionsThis document covers frequently asked questions by general practices about how the Practice Incentives Program (PIP) Quality Improvement (QI) Incentive works.
- 
  
    
Taskforce final report – Diagnostic Imaging Clinical CommitteeThis report contains the Medicare Benefits Schedule (MBS) Review Taskforce's findings and recommendations to the Australian Government on its review of Diagnostic Imaging MBS items.
- 
  
    
AISR fortnightly report no. 6 – 1 July to 14 July 2019The fortnightly Australian Influenza Surveillance Report (AISR) includes information about influenza activity, severity, impact, at-risk populations, virology, and vaccine match and effectiveness. It also gives year-to-date data and comparisons.
- 
  
    
Terms of Reference for Inquiry into Earle Haven Retirement VillageTerms of reference for an independent inquiry into the events surrounding the forced relocation of residents at the Earle Haven Retirement Village.
- 
  
    
ATAGI advice on the use of Dengvaxia® for AustraliansThis resource provides advice for immunisation providers regarding the administration of Dengvaxia® for Australians.
 
- 
  
    
Fifth National Aboriginal and Torres Strait Islander Bloodborne Viruses and Sexually Transmissible Infections Strategy 2018–2022This strategy is 1 of 5 national strategies that provide a framework for a high-quality and coordinated national response to bloodborne viruses (BBV) and sexually transmissible infections (STI) in Australia.
- 
  
    
Fourth National Sexually Transmissible Infections Strategy 2018–2022This strategy is 1 of 5 national strategies that provide a framework for a high-quality and coordinated national response to bloodborne viruses (BBV) and sexually transmissible infections (STI) in Australia.
- 
  
    
Fifth National Hepatitis C Strategy 2018–2022This strategy is 1 of 5 national strategies that provide a framework for a high-quality and coordinated national response to bloodborne viruses (BBV) and sexually transmissible infections (STI) in Australia.
- 
  
    
Third National Hepatitis B Strategy 2018–2022This strategy is 1 of 5 national strategies that provide a framework for a high-quality and coordinated national response to bloodborne viruses (BBV) and sexually transmissible infections (STI) in Australia.
- 
  
    
Eighth National HIV Strategy 2018–2022This strategy is 1 of 5 national strategies that provide a framework for a high-quality and coordinated national response to bloodborne viruses (BBV) and sexually transmissible infections (STI) in Australia.
- 
  
    
Australian Brain Cancer Research RoadmapThis Roadmap outlines the investment strategy, rationale and implementation of the Australian Brain Cancer Mission.
- 
  
    
Home Care Pricing Schedule ExampleAs a home care provider, you must include your prices for common Home Care Package services in a pricing schedule. This example shows what’s included in the schedule. You must include a copy of the schedule in all home care agreements.
- 
  
    
Outcomes of the Commonwealth Home Support Program (CHSP) wellness and reablement report 2018This report shows results of a 2018 survey of Commonwealth Home Support Program (CHSP) service providers from all states and territories, except Victoria.
- 
  
    
AISR fortnightly report no. 5 – 17 June to 30 June 2019The fortnightly Australian Influenza Surveillance Report (AISR) includes information about influenza activity, severity, impact, at-risk populations, virology, and vaccine match and effectiveness. It also gives year-to-date data and comparisons.
- 
  
    
Life Saving Drugs Program – Pompe disease – Medicines review protocolThis final protocol describes the methodology reviewers will follow to assess use of Life Saving Drugs Program medicines for Pompe disease.
- 
  
    
Life Saving Drugs Program – Mucopolysaccharidosis type II (MPS II) – Medicines review protocolThis final protocol describes the methodology reviewers will follow to assess use of Life Saving Drugs Program medicines for MPS II.
- 
  
    
Life Saving Drugs Program – Paroxysmal nocturnal haemoglobinuria – Medicines review protocolThis final protocol describes the methodology reviewers will follow to assess use of Life Saving Drugs Program medicines for paroxysmal nocturnal haemoglobinuria.
- 
  
    
Stillbirth research and educationAustralian Government response to the Senate Select Committee on Stillbirth Research and Education Report.
- 
  
    
2019 PHN Childhood immunisation coverage dataThe following spreadsheets provide quarterly 2019 data on childhood immunisation coverage by Primary Health Network (PHN) for all children and Aboriginal and Torres Strait Islander children.
- 
  
    
National Medical Workforce Strategy scoping frameworkThis framework focuses on identifying and understanding medical workforce issues that will benefit from national workforce planning.
- 
  
    
Aged care funding instrument (ACFI) monitoring report – July 2019This report shows the monthly growth in ACFI subsidies compared to estimates for July 2019.
- 
  
    
SSBA – Form – Application for extensionUse this form to apply for an extension when you are required to handle an SSBA for longer than 2 business days. Please note that this is not required when waiting for the results of confirmatory testing.
- 
  
    
SSBA – Form – Change of responsible officer detailsUse this form to report changes to the Responsible or Deputy Responsible Officer or their contact details.
- 
  
    
SSBA – Form – Change to entity and facility detailsUse this form to report changes to your entity or facility details.